Abstract:Abstract During hematopoiesis, transcription factors can not only direct differentiation of committed progenitors but also drive lineage commitment decisions from uncommitted multipotent progenitors. To further study their instructive role, we asked whether critical steps in the hematopoietic differentiation pathway could be reversed, and more specifically, whether myeloid transcription factors, C/EBP alpha and C/EBP beta, could re-direct committed T lymphoid progenitors into a myeloid fate. Previously in our laboratory, it was shown that C/EBP alpha efficiently reprograms CD19+ B cells to Mac1+ Gr1+ functional macrophages (Xie et al. (2004) Cell 117:663). To address lineage conversion of T to myeloid cells, we purified T cell subsets by MACS enrichment or FACS sorting and infected these cells with retroviruses expressing C/EBP alpha or C/EBP beta. Cells were cultured on myeloid supporting stroma with myeloid cytokines and analyzed for expression of antigens and marker genes by flow cytometry and RT-PCR. To rule out the presence of contaminating myeloid progenitors in our cultures, we started with a marked population of T lymphoid progenitors derived from Lck-Cre Rosa-EYFP reporter mice in which T cells are irreversibly marked with EYFP upon T cell commitment. T cell origin was further verified using PCR to detect TCRbeta DJ rearrangements. Using double negative DN3 and DN4 T cells, we show that a large proportion of EYFP+ DN cells infected with C/EBP alpha or C/EBP beta are induced to express surface antigens Mac1 and Gr1, express myeloid cytokine receptors and Fc receptors, and exhibit a myeloid morphology, compared to control infected cells. The reprogrammed cells are also functional as they can bind and phagocytose sheep red blood cells. In addition, the pan-T cell marker Thy1 and other T lineage genes including Lck, Rag2, and preT alpha are downregulated in reprogrammed cells. Furthermore, using a conditional knockout approach developed in Daniel Tenen’s laboratory, we show that endogenous expression of PU.1 is required for activation of Mac1 during this process. In conclusion, C/EBP alpha acts alone to extinguish the T lymphoid program while, in concert with PU.1, it activates the myeloid program leading to reprogramming of the T cell phenotype.

Alternative Enhancer Usage and Targeted Polycomb Marking Hallmark Promoter Choice during T Cell Differentiation

MLL4 Prepares the Enhancer Landscape for Foxp3 Induction Via Chromatin Looping

Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition.

Detailed Analysis of Gene Expression During Development of T Cell Lineages in the Thymus.

Promoting (and targeting) alternative expression

Foxp3 Enhancers Synergize to Maximize Regulatory T Cell Suppressive Capacity.

At the crossroads: diverse roles of early thymocyte transcriptional regulators

Thymocyte Selection: from Signaling to Epigenetic Regulation.

Super-enhancers delineate disease-associated regulatory nodes in T cells

Selective Activation of Alternative MYC Core Promoters by Wnt-Responsive Enhancers

Synergistic and antagonistic activities of IRF8 and FOS enhancer pairs during an immune cell fate switch

Temporal Gene Expression Profiles Reflect the Dynamics of Lymphoid Differentiation

Single-cell deletion analyses show control of pro-T cell developmental speed and pathways by Tcf7, Spi1, Gata3, Bcl11a, Erg, and Bcl11b

Transcriptional establishment of cell-type identity: dynamics and causal mechanisms of T-cell lineage commitment.

T To Myeloid Lineage Reprogramming By The Synergistic Action Of C/Ebp And Pu.1.

Plasma cell differentiation is controlled by multiple cell division-coupled epigenetic programs

PU.1 and BCL11B sequentially cooperate with RUNX1 to anchor mSWI/SNF to poise the T cell effector landscape

Dynamic Control of Enhancer Repertoires Drives Lineage and Stage-Specific Transcription During Hematopoiesis

Harnessing spatial transcriptomics to study fate decisions and lineage specification in T cell development

CD8+ T Cells Utilize Highly Dynamic Enhancer Repertoires and Regulatory Circuitry in Response to Infections.

Bcl11b and combinatorial resolution of cell fate in the T-cell gene regulatory network